Guangyin Wang

Title: Guangyin Wang and a Potential Route to Tetrodotoxin Production.

Introduction

Guangyin Wang is an inventor associated with Shanghai, China. His patent work describes a method for synthesizing tetrodotoxin, a compound traditionally obtained by extraction from pufferfish. The disclosed approach combines biological fermentation with chemical conversion and is presented as having potential for large-scale production.

Latest Patents

Wang is associated with 1 patent: “Method for Large-Scale Synthesis of Tetrodotoxin.” The method starts with benzyl acetate, an inexpensive and readily available raw material, and uses biological fermentation to produce an optically pure intermediate, ((5S, 6R)-5, 6-dihydroxycyclohexa-1, 3-dienyl) methyl acetate. A series of chemical conversions then yields tetrodotoxin at a stated purity of at least 95%, without purifying the product. The patent presents this process as a potential alternative to extracting tetrodotoxin from pufferfish.

Career Highlights

The supplied information associates Wang with Shanghai Shengping Medical Equipment Co., Ltd. and Vastpro (Zhejiang) Pharmaceutical Co., Ltd. His patent focuses on a synthesis route intended to support tetrodotoxin production at scale.

Collaborations

Wang’s listed coworkers include Xiaoming Li and Chengxi Wang. The available information does not specify their roles in the patent or the associated organizations.

Conclusion

Guangyin Wang’s disclosed invention combines fermentation and chemical synthesis to offer a potential alternative approach to tetrodotoxin production, with the stated aim of enabling large-scale manufacture.